PTGDR2 and rheumatoid arthritis: This study findings however provide foundation for CD4+CD183+ as a potential reliable diagnostics and prognostics biomarker for RA and disease activity as well as CD4+CD127+, CD4+CD294 and CD4+FOXP3+, since their activities have been demonstrated to contribute to prognostics of RA.